<DOC>
	<DOCNO>NCT00147953</DOCNO>
	<brief_summary>This study aim assess short term efficacy combination rituximab low-dose radiotherapy patient non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Study Evaluate Efficacy Rituximab Combination With Low-dose Radiotherapy Patients With Relapsed Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>Rituximab low-dose total-nodal irradiation show promising activity patient NHL . Moreover , radiolabelled antibody Zevalin approve treatment relapse NHL . The patient study poor prognosis . The treatment strategy aim control disease ameliorate disease relate symptom minimal toxicity . Both , rituximab low-dose radiotherapy associate minor toxicity apply alone . The primary objective study therefore assess short term efficacy combination rituximab low-dose radiotherapy patient non-Hodgkin 's lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Bcell nonHodgkin 's lymphoma At least one prior antitumor therapy ECOG performance status 02 No major organ dysfunction Written inform consent The following histology exclude : Burkitt 's lymphoma , mantlecell lymphoma , primary CNSlymphoma , HIVassociated lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>NHL</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Rituximab</keyword>
	<keyword>Palliative treatment</keyword>
</DOC>